InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Carson Lisa Cabott. Director active across 1 company, notably Phio Pharmaceuticals Corp.. In total, 2 filings have been published. History available since 11 September 2025. The latest transaction was filed on 5 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations